MERK’s net profit slipped 48.4% due to high costs of sales
16 Aug 2024 18:33
PT Merck Tbk (MERK), a pharmaceutical company under Merck Holding GmbH from Germany, booked net profit of IDR 47.2 billion in the first half (H1) of 2024.
Indofarma still on loss streak until H1 2024
02 Aug 2024 13:01
PT Indofarma Tbk (INAF), a state-owned pharmaceutical company owned through PT Bio Farma (Persero), booked a loss of IDR 101.94 billion in the first half (H1) of 2024.
Acquiring Probiotec, PYFA’s subsidiary receives IDR 1.07 trillion
12 Jun 2024 09:25
PYFA Australia Pty Ltd (PAPL), an entity under PT Pyridam Farma Tbk (PYFA), has secured extra capital of USD 99.57 million or equal to approximately IDR 1.07 trillion.
Kimia Farma's loss worsened 6 times in 2023
03 Jun 2024 08:41
PT Kimia Farma Tbk (KAEF), a state-owned pharmaceutical company through PT Bio Farma (Persero), reported worsening loss in 2023, down to IDR 1.48 trillion.
PYFA granted approval from shareholders to offer 16 billion shares in rights issue
09 Jan 2024 09:42
PT Pyridam Farma Tbk (PYFA), a pharmaceutical company operating since 1997, has managed to obtained approval during the Extraordinary General Meeting of Shareholders regarding the rights issue.
Exploring potential of pharmaceutical business, Bukit Asam teams up with Kimia Farma
10 Nov 2023 06:01
PT Bukit Asam Tbk (PTBA) is exploring cooperation in the fields of pharmaceuticals to medical devices, by signing a Memorandum of Understanding (MoU) with PT Kimia Farma Tbk (KAEF).
Soho Global Health plans for stock split with 1:10 ratio
12 Sep 2023 19:52
PT Soho Global Health Tbk (SOHO), a pharmaceutical company with a market capitalization of IDR 6.15 trillion, will carry out a stock split with a ratio of 1:10.
Kimia Farma opens 23 new outlets in various provinces
07 Jul 2023 19:29
PT Kimia Farma Tbk (KAEF) opened 23 new outlets simultaneously on Friday (7/7) today, which are spread across various provinces in Indonesia.
Merck to distribute cash dividend of IDR 143.36 billion
15 May 2023 07:21
PT Merck Tbk (MERK), a pharmaceutical company under Merck Group, Germany, announces its intention to share cash dividend of IDR 143.36 billion, equal to IDR 320 per share, that will be taken out of its net profit in 2022.
PEHA net profit soars 143%, supported by aggressive market penetration
30 Mar 2023 13:12
PT Phapros Tbk (PEHA) has posted a net profit of IDR 27.4 billion in the 2022 financial year, growing 143% year-on-year (yoy) or from the previous year which reached IDR 11.3 billion.
